380 related articles for article (PubMed ID: 18422484)
1. Mouse neuroblastoma cells release prion infectivity associated with exosomal vesicles.
Alais S; Simoes S; Baas D; Lehmann S; Raposo G; Darlix JL; Leblanc P
Biol Cell; 2008 Oct; 100(10):603-15. PubMed ID: 18422484
[TBL] [Abstract][Full Text] [Related]
2. Immunolocalisation of PrPSc in scrapie-infected N2a mouse neuroblastoma cells by light and electron microscopy.
Veith NM; Plattner H; Stuermer CA; Schulz-Schaeffer WJ; Bürkle A
Eur J Cell Biol; 2009 Jan; 88(1):45-63. PubMed ID: 18834644
[TBL] [Abstract][Full Text] [Related]
3. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
[TBL] [Abstract][Full Text] [Related]
4. Generation of genuine prion infectivity by serial PMCA.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
[TBL] [Abstract][Full Text] [Related]
5. Acute formation of protease-resistant prion protein does not always lead to persistent scrapie infection in vitro.
Vorberg I; Raines A; Priola SA
J Biol Chem; 2004 Jul; 279(28):29218-25. PubMed ID: 15133048
[TBL] [Abstract][Full Text] [Related]
6. Prion protein self-interactions: a gateway to novel therapeutic strategies?
Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
[TBL] [Abstract][Full Text] [Related]
7. Cholesterol transporter ATP-binding cassette A1 (ABCA1) is elevated in prion disease and affects PrPC and PrPSc concentrations in cultured cells.
Kumar R; McClain D; Young R; Carlson GA
J Gen Virol; 2008 Jun; 89(Pt 6):1525-1532. PubMed ID: 18474570
[TBL] [Abstract][Full Text] [Related]
8. Isolation of Exosomes and Microvesicles from Cell Culture Systems to Study Prion Transmission.
Leblanc P; Arellano-Anaya ZE; Bernard E; Gallay L; Provansal M; Lehmann S; Schaeffer L; Raposo G; Vilette D
Methods Mol Biol; 2017; 1545():153-176. PubMed ID: 27943213
[TBL] [Abstract][Full Text] [Related]
9. Specific inhibition of pathological prion protein accumulation by small interfering RNAs.
Daude N; Marella M; Chabry J
J Cell Sci; 2003 Jul; 116(Pt 13):2775-9. PubMed ID: 12759373
[TBL] [Abstract][Full Text] [Related]
10. Valproic acid treatment results in increased accumulation of prion proteins.
Shaked GM; Engelstein R; Avraham I; Rosenmann H; Gabizon R
Ann Neurol; 2002 Oct; 52(4):416-20. PubMed ID: 12325069
[TBL] [Abstract][Full Text] [Related]
11. Retrovirus infection strongly enhances scrapie infectivity release in cell culture.
Leblanc P; Alais S; Porto-Carreiro I; Lehmann S; Grassi J; Raposo G; Darlix JL
EMBO J; 2006 Jun; 25(12):2674-85. PubMed ID: 16724107
[TBL] [Abstract][Full Text] [Related]
12. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.
Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H
J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329
[TBL] [Abstract][Full Text] [Related]
13. Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody.
Enari M; Flechsig E; Weissmann C
Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9295-9. PubMed ID: 11470893
[TBL] [Abstract][Full Text] [Related]
14. Prion protein amyloid: separation of scrapie infectivity from PrP polymers.
Wille H; Baldwin MA; Cohen FE; DeArmond SJ; Prusiner SB
Ciba Found Symp; 1996; 199():181-99; discussion 199-201. PubMed ID: 8915611
[TBL] [Abstract][Full Text] [Related]
15. Infectivity-associated PrP(Sc) and disease duration-associated PrP(Sc) of mouse BSE prions.
Miyazawa K; Okada H; Masujin K; Iwamaru Y; Yokoyama T
Prion; 2015; 9(5):394-403. PubMed ID: 26555211
[TBL] [Abstract][Full Text] [Related]
16. PrP(Sc) of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification.
Shi S; Dong CF; Wang GR; Wang X; An R; Chen JM; Shan B; Zhang BY; Xu K; Shi Q; Tian C; Gao C; Han J; Dong XP
Virus Res; 2009 Apr; 141(1):26-33. PubMed ID: 19162101
[TBL] [Abstract][Full Text] [Related]
17. Non-genetic propagation of strain-specific properties of scrapie prion protein.
Bessen RA; Kocisko DA; Raymond GJ; Nandan S; Lansbury PT; Caughey B
Nature; 1995 Jun; 375(6533):698-700. PubMed ID: 7791905
[TBL] [Abstract][Full Text] [Related]
18. Packaging of prions into exosomes is associated with a novel pathway of PrP processing.
Vella LJ; Sharples RA; Lawson VA; Masters CL; Cappai R; Hill AF
J Pathol; 2007 Apr; 211(5):582-590. PubMed ID: 17334982
[TBL] [Abstract][Full Text] [Related]
19. Prion propagation and toxicity occur in vitro with two-phase kinetics specific to strain and neuronal type.
Hannaoui S; Maatouk L; Privat N; Levavasseur E; Faucheux BA; Haïk S
J Virol; 2013 Mar; 87(5):2535-48. PubMed ID: 23255799
[TBL] [Abstract][Full Text] [Related]
20. Searching for anti-prion compounds: cell-based high-throughput in vitro assays and animal testing strategies.
Kocisko DA; Caughey B
Methods Enzymol; 2006; 412():223-34. PubMed ID: 17046661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
